Sorcero, a provider of AI-driven analytics for life sciences, has acquired Axiom Health, a real-world data platform for the medical technology industry. The Axiom Health platform will be rebranded as Sorcero MedTech, creating the first unified AI solution for both pharmaceutical and medical device organizations. This integration aims to provide real-time insights for the healthcare sector.
With Axiom Health’s MedTech data lake incorporated into the Sorcero Intelligence Platform, life sciences organizations will gain a broader view of market opportunities and improved patient outcomes.
This acquisition also strengthens Sorcero’s position in the $595 billion global MedTech market. The enhanced platform will enable:
- Cross-vertical analysis of pharmaceutical, medical device, and stakeholder data
-
Rapid AI-driven insights for product development
-
A better understanding of the patient journey
-
Micro-targeting of stakeholders for precise product usage insights
-
Enhanced market intelligence for informed decision-making
The acquisition was supported by a new investment from First Trust Capital Partners, LLC, as well as additional investments from Axiom investors.
KEY QUOTES:
“The integration of pharmaceutical and medical device data unlocks critical insights that have been siloed for too long. For the first time, life sciences teams can see the complete patient journey across drugs and devices to understand treatment pathways holistically and make informed decisions about product development and commercialization. This unified view will accelerate innovation and deliver better patient outcomes.”
Dipanwita Das, CEO of Sorcero
“By combining Axiom Health’s market-leading medtech data with Sorcero’s AI platform, we can now provide a single source of truth delivering unified device and drug insights for medical and commercial teams. I look forward to enabling our MedTech customers to personalize engagement and drive measurable impact with physicians and KOLs, powered by Sorcero’s global data across stakeholders, scientific sentiment, and deeper insights into unmet patient needs.”
A. Krishna, Founder and President of Axiom Health, who now becomes Senior Vice President of MedTech at Sorcero
“We believe this strategic combination creates a differentiated platform positioned at the intersection of AI innovation and healthcare delivery. The integration of medical device commercial intelligence with Sorcero’s established pharmaceutical analytics platform addresses a critical market need while opening significant growth opportunities in the expanding life sciences AI market. We’re excited to support this transformation that we believe will help reshape how the industry leverages data to improve patient care.”
Jon Phillips, First Trust Capital Partners Managing Director
